To test whether WT1 SNP genotypes are also associated with outcome in ccRCC, we investigated the role of WT1 SNPs as candidate polymorphisms for survival in 182 patients in the context of other clinical parameters. The gene discussed is WT1; the disease is nonpapillary renal cell carcinoma.